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34 Addiction and eating disorders involve brain reward circuits. A previous history of 
35 binge eating predisposes to addictive behavior, while the cessation of exposure to drugs 
36 of abuse leads to reward activities, including intake of tasty foods. Cocaine use is 
37 associated with a decrease in food intake, with reversal after the drug use is stopped. 
38 Exciting new findings show that receptors for the "hunger" hormone, ghrelin, directly 
39 interact with the sigma-1 receptors (1R), which is a target of cocaine. 1R are key 
40 players in regulating dopaminergic neurotransmission and ghrelin-mediated actions. 
41 This review focuses on the 1 receptor as general neuroendocrine regulator by directly 
42 interacting with neuronal G-protein-coupled receptors. This review also covers the early 
43 mechanisms by which cocaine binding to 1 blocks the food-seeking behavior triggered 
44 by ghrelin. Such new findings appear as fundamental to understand common 
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50 Neuroendocrine mechanisms involving food seeking behavior involve peripheral and 
51 central players being ghrelin one of the most relevant. Ghrelin is synthesized in the 
52 stomach but its endocrine action is, among other, exerted in heart, gastrointestinal (GI) 
53 tract, pancreas and central nervous system (CNS) (Figure 1). The “hunger” ghrelin 
54 hormone mediates their actions via a specific receptor, GHS-R1a, which belongs to the 
55 family of G-protein-coupled receptors (GPCRs). Dopamine, one of the main 
56 neurotransmitters in the brain is involved in the circuits in which neuronal GHS-R1a 
57 expression occurs. Also, dopamine is central to the actions of a variety of drugs of 
58 abuse, in particular of cocaine. Despite cocaine was first used by South America tribes 
59 for endurance and appetite suppression, little was known about the underlying 
60 mechanisms. Recent results show that one atypical receptor of unknown physiological 
61 function, the sigma-1 receptor (1R), is a key piece in the puzzle constituted by 
62 interrelationships between cocaine and food seeking behaviors. First, this review covers 
63 the role of 1R in cocaine addiction via regulating dopaminergic transmission mediated 
64 by GPCRs. The second part of the paper reviews recent data showing how sigma 
65 receptors regulates ghrelinergic signaling. Finally, the review presents the novel and 
66 relevant evidence linking cocaine suppression of appetite with both cocaine binding to 
67 1R and regulation via 1R of the function of dopamine and ghrelin GPCRs.
68 Apart from acting via inhibition of dopamine transporters in neurons, cocaine is able to 
69 interact with sigma-1 and sigma-2 receptors. Not only the physiological role of the two 
70 receptors is unknown but they are structurally unrelated despite they share the same 
71 name (sigma). This review focuses on sigma-1 receptor (1R) as a mediator of the 
72 anorexigenic effect of cocaine. The receptor whose function remains a mystery displays 
73 interesting features such as i) its capacity to bind cocaine at physiologically-relevant 
74 concentrations and ii) evidence on modulating G-protein-coupled receptors (GPCRs), 
75 which in turn mediate the effects of drugs of abuse and of orexigenic hormones. 
76 Already in 1991, evidence was provided on blockade of stimulant effect of cocaine by 
77 targeting 1R (Menkel et al. 1991). It should be noted that treatment with synthetic 
78 drugs acting on 2 receptors decrease some of cocaine-induced effects (Matsumoto et 
79 al. 2007) and that antagonist of the receptors counteract induced locomotor stimulation 
80 in cocaine-administered mice (Lever et al. 2014). However, the research on 2 receptor 
81 research is still too preliminary to allow establishing solid link between the receptor and 
82 addiction mechanisms. One of the novel aspects in the review, which is based on recent 
83 results, is the advance in understanding how cocaine consumption reduces food seeking 
84 behavior. Apparently, this is due to direct interactions with the receptor for the hunger 
85 hormone, ghrelin.
86 The most striking and accepted effect of cocaine in brain is an increase in inter- and 
87 extra-synaptic dopamine concentration that leads to marked activation of dopamine 
88 receptors. These and many other neuronal receptors belonging to the family of G-
89 protein-coupled receptors use cAMP as second messenger. IUPHAR information for 
90 sigma receptors shows their atypical nature as they do not use either cAMP or any other 
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91 second messenger as calcium ions or inositol-3-phosphate. As  1R are not coupled to 
92 any known signal transduction machinery IUPHAR states that “there is only a modest 
93 pharmacological overlap and no structural convergence with the GPCRs” 
94 (http://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=785). 
95 On the other hand, structurally different compounds may bind to 1R receptors at 
96 topologically intracellular sites. In fact, the binding of a drug seemingly acting on 
97 opioid receptors suggested that 1R receptors belonged to the opioid receptor family. 
98 The uniqueness of the receptor was first confirmed by lack of effect of opioid receptor 
99 antagonists and, secondly, by cloning and discovery of the non-GPCR structure. 
100 Solving of 3D structure (see details below) has confirmed some of the assumptions 
101 about these receptors and has provided brand new information related to atypical 
102 membrane insertion and seemingly physiological trimeric structure. 
103
104 Evidence of relevant role of 1R receptors on cocaine addiction
105 A synthetic opioid-like molecule, SKF-10,047, displays psychomimetic activity while it 
106 does not selectively bind to μ- or k-opioid receptor.  Although it was firstly assumed 
107 that the compound could bind to a novel opioid receptor (Martin et al. 1976), its effect 
108 was not blocked by nonselective opioid receptor antagonists  (Vaupel 1983). The 
109 compound binds to a protein (1R) whose cloning showed that it does not have seven 
110 transmembrane domains (Hanner et al. 1996). While waiting for more precise detailed 
111 of its physiological role, the 1R is considered a pluripotent modulator able to interact 
112 with different specific proteins (e.g. binding immunoglobulin protein -BiP-), cell 
113 components and/or signal transduction machineries (Su et al. 2016). 1R may interact 
114 with receptors for a variety of hormones/neurotransmitters and modulate either/or cell 
115 surface expression and function. Research on this protein is gaining momentum due to 
116 its potential as target to combat  neuropathic pain (Mei & Pasternak 2002; Corbera et al. 
117 2006; Sun et al. 2016). Agonistic activity in the case of 1R may be indirectly measured 
118 by subcellular translocation, establishment of protein-protein interactions and by 
119 regulation of ion channel activity (Wu & Bowen 2008; Kim et al. 2010; Navarro et al. 
120 2010; Su et al. 2010). Indirect evidence also shows the involvement of 1R in disorders 
121 such as depression (Su et al. 2010). Also interesting is the correlation between a 
122 mutation in the receptor and debut and progression of juvenile lateral amyotrophic 
123 sclerosis (Al-Saif et al. 2011; Mavlyutov et al. 2013). More recently, a biophysical 
124 approach assessing homomerization of 1R and heteromerization of 1R with BiP has 
125 allowed distinguishing molecules with differential potential on stabilizing 
126 multimerization of the receptor and/or facilitating the 1R/BiP interaction (Yano et al. 
127 2018). Despite the ambiguity of the words agonist/antagonist in the case of this specific 
128 receptor, the authors show that haloperidol and (+)-pentazocine have opposite effects, 
129 thus paving the way to effectively test or select molecules with “agonistic” versus 
130 opposite (“antagonistic”) action.
131 Solving the 3D structure (Schmidt et al. 2016) provided another unexpected finding as 
Page 4 of 23
jme@bioscientifica.com
Manuscript submitted for review to Journal of Molecular Endocrinology
For Review Only
5
132 the 1R does not have, as previously hypothesized, two transmembrane domains and 
133 extracellular C- and N-terminal domains, but an extracellular N-terminal end a 
134 transmembrane helical domain and a C-terminal tail having a cupin-like β-barrel with 
135 a buried ligand-binding site. Crystals also show an arrangement consisting of three 
136 closely interacting 1R protomers. Despite homology (relatively poor) with a fungal 
137 sterol isomerase (Cobos et al. 2008), no catalytic activity has been yet allocated to 1R.
138 Due to the reports showing that the 1R may interact with receptors for a variety of 
139 hormones/neurotransmitters (see below), it was tempting to speculate that the role of the 
140 receptor may be regulation of the expression and function of cell surface receptors. 
141 (Kruse 2016) has recently reviewed the intriguing features of this protein, with no 
142 structural resemblance with any other membrane receptor, occluded ligand binding site, 
143 and resemblance to a yeast enzyme, yeast sterol isomerase. Remarkably, while the 
144 physiological function remains elusive and the endogenous ligand is yet to be 
145 discovered, cocaine binds to 1R, which mediate some effects of the drug (Skuza 1999; 
146 Shull 2002; Lever et al. 2016). The design of drugs impeding the interaction of cocaine 
147 with 1R is proposed to reduce drug-seeking behavior (Matsumoto et al. 2001a). 
148 Remarkably, 1R-mediated cocaine actions in the central nervous system are dependent 
149 on molecular interactions with dopamine and other neuron-expressed GPCRs. 
150
151 Cocaine drives many of its effects via interacting with 1R
152 To our knowledge there are few reports addressing cocaine binding to 1R. It is 
153 however relevant that compared with other drugs of abuse the cocaine interaction with 
154 1R was suspected several years ago (see (Hayashi & Su 2007) for review). Pioneering 
155 studies of cocaine binding to 1R were performed in 2001 ((Matsumoto et al. 2001b). 
156 Competition assays in radioligand binding studies showed that Ki of cocaine was 2.3 in 
157 mouse and 2.9 µM in rat brain. Values were similar in mice brain membranes (Lever et 
158 al. 2016) thus confirming that at “physiological” concentrations occurring after cocaine 
159 exposure the drug binds to 1R. Based on their results Matsumoto et al., 2003 proposed 
160 that 1R were targets to combat cocaine addiction. More recently, in a detailed study 
161 (Lever et al. 2016) showed that cocaine administration to mice reduces the binding to 
162 1R of a radiolabeled ligand and it does so in a similar proportion in the 20 different 
163 brain regions analyzed by quantitative autoradiography. Average reduction of specific 
164 binding after i.p. administration of 100 µmol/kg cocaine was 54%. It should be noted 
165 that the 1R was expressed in all brain regions in a narrow range of 2-4 fmol/mg tissue. 
166 A significant advance in addiction research has been provided by mechanisms of 1R 
167 linkage to the MAP kinase pathway. The receptor itself or upon cocaine binding cannot 
168 convey signals that impact on such key signaling pathway. The answer for this 
169 conundrum is the role of GPCRs that are able to directly binding to 1R. Then the most 
170 reasonable assumption is that cocaine binding to 1R produce conformational changes 
171 to cell surface GPCRs that are in direct contact with 1R. This possibility not only 
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172 affects signaling by also the overall biology of GPCRs relevant in addiction and also 
173 relevant in the control of food intake.
174 A first and in deep review on the role of 1R in the many different sides of cocaine 
175 addiction was provided in 2002 by (Romieu et al. 2002). The already existing data 
176 made authors state: “1R is not only necessary for acquisition of the cocaine-induced 
177 conditioned place preference, but that it is also implicated in its expression, confirming 
178 that activation of the 1R is induced during cocaine's early effects”. A very recent 
179 review summarizes the main properties of 1R and makes emphasis in its role as 
180 chaperone (see (Katz et al. 2017) and references therein). The review also presented the 
181 evidence of receptor involvement in three specific aspects of drug addiction, namely 
182 self-administration, discrimination and place-conditioning. We will here focus on the 
183 molecular mechanisms that are triggered by cocaine binding to 1R, but executed by  
184 other proteins. (Katz et al. 2017) propose that there is a “concomitant targeting of both 
185 dopaminergic pathways and σR proteins”. However, recent evidence is more consistent 
186 with a more direct effect of cocaine on dopaminergic transmission and on other 
187 signaling systems operating in neurons of reward circuits. It is quite noteworthy that 
188 (Romieu et al. 2002) were able to intuitively notice this possibility as they also stated in 
189 their review: “The 1R is activated consequently to dopamine reuptake blockade and is 
190 not sufficient to induce conditioned place preference (CPP) by itself. The mechanism of 
191 the 1R involvement in CPP and the selectivity toward the CPP-inducing drug remains 
192 however to be determined”. In fact, data in the last decade suggest new possibilities that 
193 have increased the knowledge of the molecular mechanisms underlying cocaine action. 
194 In what concerns dopaminergic signaling it may happen that cocaine binding to 1R 
195 produces an almost direct effect on dopaminergic transmission. This is possible because 
196 1R directly interact with dopamine receptors and, accordingly, cocaine is binding to 
197 and affecting the structure and function of 1/dopamine receptor complexes. 
198
199 Lessons from drugs behaving as 1R ligands
200 Pioneering studies related to the role of 1R in cocaine actions, showed that NPC 
201 16377, a compound able to bind to these receptors was protective against toxic and 
202 behavioral effects of cocaine. NPC 16377 did not show any noticeable side effect while 
203 its efficacy was quite marked; for instance, it totally prevented the development of 
204 cocaine sensitization and significantly reduced diazepam-sensitive cocaine convulsions. 
205 Its effects were quite selective as it did not behave like NMDA receptor ligands and was 
206 not efficacious against the discriminative stimulus triggered by other drugs (Witkin et 
207 al. 1993). Similar results were obtained using different chemical structures, i.e. 
208 compounds able to reduce cocaine-induce hyperlocomotion and  convulsions, were able 
209 to bind to 1R but not to receptors for neurotransmitters (McCracken et al. 1999; Shull 
210 2002).
211 (Skuza 1999) tested different 1R ligands, inter alia rimcazole and panamesine, on 
212 cocaine-induced locomotor activity and convulsions. Whereas panamesine was effective 
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213 in the two actions of the drug, rimcazole increased the total time of cocaine-evoked 
214 convulsions and locomotor activity. Simultaneous administration of the assayed 
215 compounds showed that the effect of a given molecule could be reverted by another 
216 one. Skuza concluded: “2R subtype is involved in psychomotor stimulant effects of 
217 cocaine while 1R subtype participates in the cocaine-induced convulsions”. However, 
218 (Matsumoto et al., 2001) showed that rimcazole is acting via 1R. Authors tested 
219 different concentrations of analogs of rimcazole for their ability to bind to the two main 
220 targets of cocaine, dopamine transporters and 1R. Authors were successful in showing 
221 that drugs protective against convulsion-producing concentrations of cocaine were not 
222 acting via dopamine transporter inhibition but via binding to 1R. Also (Romieu et al. 
223 2000) showed that two novel 1R ligands, BD1063 and BD1008, significantly increased 
224 the ED50 for the locomotor effects of cocaine. In a follow up study six analogues of 
225 BD1008 were tested against a variety of targets showing significant affinity for 1R, 
226 moderate for 2R and low or very low affinity for dopamine, opioid, NMDA and 5-
227 hydroxytryptamine  receptors or dopamine transporters (Matsumoto et al. 2004). The 
228 role of 1R was reinforced using an antisense oligodeoxynucleotide approach, which 
229 was efficacious in reducing the behavioral effects of cocaine (Matsumoto et al., 2001). 
230 Taking into account all the cumulative evidence, antagonists of 1R were proposed as 
231 therapeutic agents against cocaine addiction (Matsumoto et al., 2003; Matsumoto et al., 
232 2001; Maurice and Romieu, 2004). It should be however noted that 1R-based therapies 
233 may not work on acute symptoms and may be better suited to address drug sensitization. 
234 Indeed, a common phenomenon displayed by all ligands tested is reduction in 
235 psychostimulant-induced sensitization, not only to cocaine but to methamphetamine 
236 (Ujike et al. 1996). 
237 1R impact on signaling pathways originating at GPCRs and also on the function of ion 
238 channels; overall these functional interactions shape the behavioral and neuroanatomical 
239 plastic actions of cocaine (Kourrich et al. 2013). One of the first relevant aspects to 
240 consider is how 1R may affect dopaminergic signaling. As an example, the D1 receptor 
241 mediated signaling and dopamine-induced inositol 1,4,5-trisphosphate production has 
242 been studied in dissociated neurons of the nucleus accumbens (NAc). The main finding 
243 was that the calcium mobilization produced by injection of inositol 1,4,5-trisphosphate 
244 was enhanced by cocaine in a 1R-dependent fashion. Not only cocaine increases the 
245 effects of agonists on cAMP levels but it alters the kinetics of the MAP kinase pathway 
246 engagement. Remarkably D1 and 1 receptors do interact and the cocaine effects were 
247 dependent on 1R, a fact that was confirmed by using 1R KO mice (Navarro et al. 
248 2010).  
249
250 Cocaine, dopamine, dopamine receptors and dopamine heteroreceptor complexes
251 Dopamine is one of the main neurotransmitters in the brain, and their actions, mediated 
252 by dopamine receptors, are relevant for inter alia motor control and reward circuits 
253 targeted by addicting drugs. Pioneering electrophysiological studies by (Uchimura & 
Page 7 of 23
jme@bioscientifica.com
Manuscript submitted for review to Journal of Molecular Endocrinology
For Review Only
8
254 North 1990) showed that intracellular recordings in neurons triggered by 5-
255 hydroxytryptamine  or by dopamine in the NAc were affected by cocaine. The drug at 
256 doses in the 1-30 µM range affect dopamine D1-receptor mediated hyperpolarization 
257 and D2-receptor mediated depolarization. Cocaine was more effective, i.e. less doses 
258 were required, to alter the actions of 5-hydroxytryptamine.
259 In many circumstances a GPCR-containing heteroreceptor complex arises as the actual 
260 functional unit. In cocaine addiction, the engagement of 1R by cocaine and the 
261 interaction of these receptors with GPCRs has led to investigate how heteromers may 
262 contribute to the behavior and motor effects of the drug. As an example, complexes 
263 formed by dopamine D1 and histamine H3 receptors display particular properties as the 
264 heteromer is needed for signaling to the MAP kinase pathway (Ferrada et al. 2009). 
265 Cocaine alters heteromer function and it does so by a 1R-dependent mechanism 
266 (Moreno et al. 2014). These results probably reflect a macromolecular complex 
267 constituted by H3, D1 and 1 receptors whose structure and function becomes altered in 
268 the presence of cocaine. This interpretation is supported by the finding that antagonists 
269 of 1R restores the homeostatic interplay between H3 and D1 receptors and, therefore, 
270 supports therapeutic possibilities for 1R antagonists to combat drug addiction. 
271 Cocaine affects signaling of other dopamine-receptor containing heteromers also in a 
272 1R-dependent fashion. Adenosine A2A and dopamine D2 receptor heteromers were 
273 among the first identified GPCR heteromers (Hillion et al. 2002); they play a relevant 
274 role in the striatum and are the target for therapeutic approaches addressed to combat 
275 Parkinson’s disease. On the one hand, energy transfer studies showed that cocaine 
276 altered the structure of adenosine receptor homomers and of adenosine/dopamine 
277 receptor heteromers. On the other hand the drug affected some but not all of the 
278 signaling pathways engaged by activation of D2 receptors (Marcellino et al. 2010). 
279 Taking into account available data on the molecular mechanisms of cocaine actions 
280 (Borroto-Escuela et al. 2016) hypothesize that the drug is significantly altering the 
281 allosteric interactions occurring in homo- and heteroreceptor complexes, especially in 
282 those containing dopamine receptors. Taking also into account receptor distribution in 
283 different brain regions and changes in receptor expression after cocaine exposure the 
284 authors suggest that anti-cocaine actions of A2A agonists do not depend on 
285 heteromerization with D2 receptors, but that cocaine self-administration courses with a 
286 loss in the brake on the D2 receptor signaling within the A2AR-D2R receptor 
287 heteroreceptor complex in dorsal striatopallidal GABA neurons. Apart from the well-
288 known fact that cocaine markedly enhances the extracellular levels of dopamine in 
289 several regions of the central nervous system, little is known on the mechanism 
290 underlying drug addiction. Cocaine administration to non-human primates results in 
291 brain concentration peaks appearing as soon as 5 min to go back to basal at 30 min 
292 (Bradberry et al. 2000). A key region for addiction behavior establishment is the NAc.
293 A novel technique of heteromer detection shows that cocaine self-administration 
294 increases the expression of A2A/D2 and D2/1R complexes in the shell of the NAc 
295 whereas decrease those constituted by D2 and 1R in the dorsal striatum (Borroto-
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296 Escuela et al. 2017). Thus, self-administration likely increases in a regional selective 
297 way the expression of receptors that may establish direct interactions and have 
298 particular signaling pathways. It should be noted that 1R may form heteromers with D2 
299 receptors but not with other D2-like receptors such as D3 or D4 receptors. The drug 
300 inhibits dopaminergic signaling in the striatum of wild type mice but not in the striatum 
301 of 1R KO mice. As commented below cocaine also affects D1-receptor mediated 
302 signaling thus altering the D1-D2 functional balance required for proper motor control 
303 (Navarro et al. 2013). This 1R mediated effect on striatal dopaminergic signaling is 
304 probably one of the main factors underlying locomotor actions of cocaine. 
305 A small but significant percentage of neurons in the NAc express D1 and D2 dopamine 
306 receptors. There is  dispute on the possibility that D1 and D2 may form heteroreceptor 
307 complexes in the motor control brain areas (Lee et al. 2004; Rashid et al. 2007; 
308 Perreault et al. 2010; George et al. 2014; Frederick et al. 2015; Rico et al. 2016). The 
309 most likely hypothesis is that 10-20% of neurons in the NAc express both receptors that 
310 establish heteroreceptor complexes shifting dopaminergic transmission from cAMP- to 
311 Ca2+-dependent signaling (Hasbi et al. 2009). As the increase of dopamine in this 
312 nucleus is fundamental for addiction and a significant amount of these cells express the 
313 two dopamine receptors, it is hypothesized that D1/D2 heteroreceptor complexes are 
314 important for establishment of cocaine seeking behavior. In line with this hypothesis, 
315 recent studies show that disruption of the heteromer has profound consequences in 
316 animals treated with cocaine. Intracerebroventricular administration of disrupting 
317 peptides, induces, sustains, accelerates and exacerbates the incentive motivational and 
318 locomotor activating effects of cocaine in a self-administration paradigm. The blocking 
319 peptides were also able to increase ∆FosB expression in the NAc. These findings 
320 suggest a model for tonic inhibition of basal and cocaine-induced reward (Perreault et 
321 al. 2016). Future experiments should address the question of whether 1R may interact 
322 with D1/D2 heteroreceptors and mediate cocaine actions in neurons expressing the two 
323 dopamine receptors.
324
325 Cocaine alters mitogen activated protein kinase (MAP) pathway via GPCRs
326 One of the common factors in drug addiction is the involvement of the MAP kinase 
327 pathway. Many drugs of abuse and, also, natural compounds with psychoactive effects 
328 impact on the pathway. Structurally different drugs such as tetrahydrocannabinol (THC) 
329 or cocaine increase the phosphorylation of extracellular signal-regulated kinases (ERKs) 
330 in different brain regions, and pharmacological blockade of the pathway impairs 
331 conditioned place preference. Furthermore, activation of the MAP kinase pathway 
332 seems to contribute to the cerebral plastic changes induced by drugs of abuse (see 
333 (Valjent et al. 2004) and references therein). Activation of the MAP kinase pathway is 
334 needed for establishing an association between drug consumption and conditioned place 
335 preference (Valjent et al. 2006; Du et al. 2017). Of the two predominant ERK isoforms, 
336 ERK2 seems more directly involved in plasticity changes produced by repeated 
337 exposure to cocaine. This conclusion arises from data in ERK1 KO mice, which display 
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338 a facilitation of acquisition of cocaine conditioned place preference and of locomotor 
339 sensitization (Ferguson et al. 2006). Also interesting is the finding that dopamine D1 
340 receptor mediates cocaine-induced long-term plasticity in the NAc (Zhang et al. 2017). 
341 On the one hand, dopamine supersensitivity subsequent to cocaine consumption alters 
342 the homeostasis of the pathway. Although the temporal course of cocaine-induced 
343 increase of dopamine occurs mainly in ventral striatum (Kalivas 1993; Kalivas & Duffy 
344 1993), it affects other brain regions in virtue of the volume transmission mechanism 
345 defined by (Agnati et al. 1986); dopamine does so probably in close but diverse regions 
346 within the reward circuits. On the other hand, whereas THC or caffeine acts by direct 
347 binding to GPCRs, a direct effect of cocaine of those receptors is unlikely. Interestingly 
348 enough, cocaine binding to 1R do impact on the signal transduction mechanisms that 
349 originate at GPCRs and regulate the MAP kinase and mTOR pathways (see (Franco et 
350 al. 2017) and references therein). In the amygdala, which is also is affected in cocaine 
351 addiction, acute and chronic drug administration produced different patterns of 
352 immediate early gene expression by mechanisms dependent on ERK activation 
353 (Radwanska et al. 2005).  Therefore, the MAP kinase pathway arises as a key mediator 
354 of the central actions produced in response to cocaine administration. 
355
356 Orexin and ghrelin receptors 
357 A review of the literature on orexin/hypocretin physiology and orexin receptor 
358 pharmacology made (Kukkonen and Leonard, 2014;  Leonard and Kukkonen, 2014) 
359 suggest that orexigenic receptors could be therapeutic targets of food disorders and drug 
360 addiction. Such hypothesis is partly based on the fact that orexin G-protein-coupled 
361 receptor pharmacology is multifaceted ranging from activation of canonical signaling 
362 pathways to regulation of ion fluxes. 
363 Cocaine-seeking behavior involves several mediators such as orexin-A and 
364 corticotropin-releasing factor (CRF) acting in the ventral tegmental area. Again, 
365 receptors related with cocaine effects have the possibility of forming heteromers whose 
366 function is affected by the drug. As a relevant example CRF1 (CRF1R) interact with 
367 orexin OX1 receptors and the interaction results in a negative crosstalk between orexin-
368 A and CRF; these neuroregulators/hormones regulate dendritic dopamine release in the 
369 ventral tegmental area. But the 1R also interacts with GPCR heteroreceptor complexes 
370 and cocaine binding to 1R sensitizes cells to excitatory effects of CRF and orexin A; 
371 the mechanisms consists of the cross-talk between CRF1-OX1 receptors (Navarro et al. 
372 2015). These results reflect an interplay between addiction, stress and, importantly, 
373 control of food intake by orexigenic factors. 
374 Ghrelin is a peptide hormone that controls food intake and energy homeostasis (Figure 
375 1). Its action is mediated by specific receptors that have received a variety of 
376 denominations, inter alia growth hormone-releasing peptide or growth hormone 
377 secretagogue receptor. Ghrelin receptors belong to the superfamily of G-protein-coupled 
378 receptors (GPCRs) and, up to date, only one type has been identified. The full length 
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379 388 amino-acid-long human ghrelin receptor containing seven transmembrane domains 
380 is known as GHS-R1a, to differentiate it from the GHS-R1b splice variant, which is 289 
381 amino acid long and lacks the 5th and 6th transmembrane (TM) domains. These TM 
382 domains are required for coupling to heterotrimeric G proteins and, therefore, ghrelin 
383 cannot signal via GHS-R1b receptors (Mary et al. 2013). The truncated variant seems to 
384 serve as modulator of GHS-R1a surface expression and signaling. In fact, GHS-R1b is 
385 expressed in the same cells than GHS-R1a and both receptors interact to form heteromer 
386 receptor signaling units (Mary et al. 2013). It has been reported that GHS-R1b 
387 negatively influences ghrelin action by reducing surface expression of functional G-
388 protein-coupled ghrelin receptors (Chow et al. 2012) and by allosteric interactions that 
389 reduce the efficacy of the hormone (Mary et al. 2013). 
390 In a detailed review (Schellekens et al. 2013a) nicely summarize how activation of 
391 specific receptors in the brain shapes the many actions of the so-called hunger hormone. 
392 The link between ghrelin and dopaminergic transmission in reward circuits is 
393 highlighted: “The ghrelin signaling system has recently been suggested to play a key 
394 role at the interface of homeostatic control of appetite and the hedonic aspects of food 
395 intake, as a critical role for ghrelin in dopaminergic mesolimbic circuits involved in 
396 reward signaling has emerged”. They also point out that ghrelin receptors may establish 
397 interactions with other proteins that may shape the central effects of ghrelin 
398 (Schellekens et al. 2013a, b). In fact, ghrelin receptors may establish direct protein-
399 protein interactions with a variety of GPCRs: dopamine, melanocortin, prostanoid, 
400 serotonin,  somatostatin and neurotensin receptors ((Borroto-Escuela et al. 2014); see 
401 www.gpcr-hetnet.com and references therein). In a detailed study in which complexes 
402 formed by GHS-R1a-GHS-R1b and dopamine D1 receptors were detected, differences 
403 in the function of ghrelin receptor signaling was found in hippocampal versus striatal 
404 neurons. In the latter D1 receptors were involved in GHS-R1a-Gs/olf coupling. Thus, 
405 the dopamine receptor may switch from Gi/o to Gs/olf coupling but only if GHS-R1b  is 
406 also expressed (Navarro et al. 2016). It then appears that anything affecting D1 receptor-
407 mediated signaling may in turn affect ghrelin actions.
408
409 Links between drug addiction and anorexic behavior
410 Used today as recreational drug, cocaine was first consumed by humans in the form of 
411 Coca leaves. Indeed, indigenous peoples of South American knew that chewing coca 
412 leaves was key for keeping their life style, especially in living within high mountains. 
413 Coca served to cope with the harsh living conditions, for instance when people had to 
414 travel long distances and cross Andean mountains with reduced weight and little food.  
415 Despite such ancient knowledge, i.e. the appetite suppressant action of cocaine 
416 consumption, the molecular basis of hunger dissipation by cocaine have remained 
417 elusive. Interestingly, years ago (Cottone et al. 2012) showed that antagonists of 1R 
418 blocked compulsive eating behavior in rats. These early results fit nicely with those of a 
419 recent report that has provided insight into the underlying molecular mechanisms.
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420 It has been established that addiction and eating disorders (e.g. binge eating, anorexia, 
421 bulimia) share a central control that involves reward circuits in the brain. This leads to 
422 bidirectional influences: on one hand, previous history of binge eating predisposes to 
423 the addictive behavior whereas the cessation of exposure to drugs of abuse leads to 
424 persistent proclivity towards reward-providing activities, including the intake of 
425 palatable foods. From ancient times, it has been known that the use of cocaine is 
426 associated with decreased food intake, with the inversion after the drug use is stopped. 
427 This creates a vicious circle in which the weight gain that follows the discontinuance of 
428 cocaine use secondarily causes a significant distress which can make a patient more 
429 prone to the relapse. Many uncertainties remain about the biological substrate of these 
430 changes, particularly at the level of signaling systems involved. Thus, establishing the 
431 molecular mechanisms of such complex interactions is of immense biological and 
432 medical importance. 
433 Exciting new findings substantiate the concept that the receptors for “hunger” hormone, 
434 ghrelin, on neurons in the CNS directly interact with 1R. The results provide solid 
435 evidence of the anorexic effect of cocaine being mediated by ghrelin receptors, that 
436 arise as both key players in the central control of food/energy intake and sensitive to 
437 1R-mediated cocaine effects. Importantly, the ghrelin/1R interaction creates 
438 qualitatively new, higher-order structures, with altered signaling properties. Unraveling 
439 the mechanisms applicable in this setting may ultimately translate into the new 
440 approaches relevant for numerous other areas of research (e.g. endocrinology, 
441 behavioral neuroscience), as well as for addressing the societal impact of these 
442 disorders, particularly in the youth population.
443
444 Cocaine affects ghrelin receptor traffic and function via 1R
445 A first relevant piece of information concerning cocaine and ghrelin receptors is the fact 
446 that the drug alters the expression of GHS-R1a at the membrane level. Cocaine at a 
447 physiologically relevant dose (Navarro et al. 2010) is able increase plasma membrane 
448 expression of 1R. The so-called 1R agonists do the same effect thus confirming a very 
449 specific effect. Remarkably both cocaine and 1R agonists increase the colocalization of 
450 the two receptors at the cell surface. Accordingly, any drug interacting in an “agonistic” 
451 manner with 1R is able to concomitantly affect coexpression of the two receptors at the 
452 cell surface where they keep direct-direct interactions a deduced from assays in brain 
453 sections for cocaine-treated animals and in an heterologous expression system 
454 (Aguinaga et al. 2018); manuscript in revision; first version included as Supplementary 
455 information). 
456 The in situ proximity ligation assay (Borroto-Escuela et al., 2016) allows determining 
457 the occurrence of receptor complexes in natural sources. The technique showed 
458 occurrence of 1/GHS-R1a receptor heteromeric complexes in rat brain sections. 11% 
459 of cells in rat striatum displayed the fluorescent signal corresponding to heteromers. In 
460 animals chronically treated with the addictive drug the percentage of positive cells 
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461 increased to 61% and the amount of signal, measured as red clusters also increased. The 
462 acute treatment lead to a more marked increase in both percentage of labelled cells 
463 (76%) and degree of labelling (3.2-fold increase). The results are consistent with both 
464 the occurrence of 1/ghrelin receptor complexes and a marked upregulation of those 
465 complexes upon acute or chronic cocaine treatment. Upregulation of 1/GHS-R1a 
466 receptor heteromeric complexes was also obtained in primary cultures of primary 
467 striatal neurons treated with cocaine. This finding led to the hypothesis that cocaine 
468 binding to ghrelin receptors could affect the ghrelin-receptor mediated signaling. The 
469 hypothesis addressed both in a heterologous expression system and primary cultures of 
470 striatal neurons led to similar findings. 
471 Consistent with the coupling of ghrelin receptor to heterotrimeric Gi proteins, its 
472 activation using the endogenous ghrelin in the presence of forskolin significantly 
473 decreases intracellular cAMP levels. Signaling via Gi was blocked by both agonists of 
474 1R and by cocaine. Signal transduction in neurons expressing GHS-R1a leads to 
475 activation of the MAP kinase pathway. This signaling, i.e. ERK phosphorylation 
476 triggered by GHS-R1a activation was not only inhibited by ghrelin receptor antagonists 
477 but by cocaine and 1R agonists (Figure 2). Therefore, both G-dependent and G-
478 independent signaling becomes compromised by cocaine binding to 1R and disappear 
479 when 1R is silenced by a siRNA methodology. 
480 A further relevant question was to know whether the cocaine effects were mediated by 
481 either 1 containing heteroreceptor complexes or by indirect mechanisms involving 
482 second messengers or other signaling molecules. Cocaine acting as agonist of the 
483 receptor may stabilize its trimeric structure (Gromek et al. 2014). Taking advantage of 
484 the (trimeric) 3D-structure of 1R (Schmidt et al. 2016) a model was proposed for the 
485 1R- GHS-R1a interaction. The model predicted that the transmembrane 1 (TM1) 
486 domain of the ghrelin receptor form participates in the interaction interface whereas 
487 TM7 does not. The issue can be addresses taking advantage of interfering peptides. 
488 They have been successfully used to disrupt the structure of interactions involving 
489 GPCRs (Navarro et al. 2018). The peptides consist of receptor TM sequences followed 
490 by a short sequence of the cell-penetrating HIV transactivator of transcription (TAT) 
491 that is responsible of cell membrane penetrance (Schwarze et al. 1999). In agreement 
492 with the model provided for 1R- GHS-R1a heteromers, the TAT-TM1 but not the 
493 TAT-TM7 achieved a lack of effect of cocaine on GHS-R1a-mediated signaling while 
494 the ghrelin action was still blocked by the selective ghrelin receptor antagonist. In 
495 summary, at the mechanistic level the cocaine blockade of ghrelin action occurs at a 
496 proximal level in CNS neurons by a direct action of 1R directly interacting with 
497 ghrelin receptors (Figure 2).
498
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814 Legend to figures
815 Figure 1. Endocrine actions of ghrelin in different body organs. Ghrelin is produced 
816 in the stomach (yellow) and exerts actions in different parts of the mammalian body. 
817 Examples of organs and actions are in green circles.
818 Figure 2. Mechanisms of ghrelin receptor-mediated cocaine-suppression of 
819 appetite. In the absence of cocaine, the peptide hormone ghrelin arrives to the CNS 
820 and activates GHS-R1a in CNS neurons to engage Gi signaling and the MAPK 
821 pathway (left). In the presence of cocaine activation of 1 produces conformational 
822 changes in GHS-R1a (see Aguinaga et al., 2018) that blocks any signaling 
823 originating at the ghrelin receptor (right). The chemical structure of cocaine is shown 
824 near the coca leaf.
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Figure 1. Endocrine actions of ghrelin in different body organs. Ghrelin is produced in the stomach (yellow) 
and exerts actions in different parts of the mammalian body. Examples of organs and actions are in green 
circles. 
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Figure 2. Mechanisms of ghrelin receptor-mediated cocaine-suppression of appetite. In the absence of 
cocaine, the peptide hormone ghrelin arrives to the CNS and activates GHS-R1a in CNS neurons to engage 
Gi signaling and the MAPK pathway (left). In the presence of cocaine activation of 1 produces 
conformational changes in GHS-R1a (see Aguinaga et al., 2018) that blocks any signaling originating at the 
ghrelin receptor (right). The chemical structure of cocaine is shown near the coca leaf. 
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